Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2

Min Yang, Jingwei Liu, Jianghua Shao

  • 1Beijing Anzhen Hospital, Capital Medical University, Beijing, China. jdu@bcm.edu.

Molecular Cancer
|March 4, 2014
PubMed
Abstract

Insights

Cathepsin S (Cat S) promotes colon cancer by activating autophagy and M2 polarization in tumor-associated macrophages (TAMs). Inhibiting Cat S may offer a new cancer therapy strategy targeting these processes.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Tumor-associated macrophages (TAMs) are key leukocytes in tumors, but their specific molecular drivers of malignancy are unclear.
  • Autophagy is crucial for tumor cell survival, yet its link to TAM polarization remains poorly understood.

Purpose of the Study:

  • To investigate the role of Cathepsin S (Cat S) in regulating TAM polarization and autophagy in colon cancer.
  • To explore Cat S as a potential therapeutic target for colon carcinoma.

Main Methods:

  • Analysis of Cat S expression in human colon cancer tissues.
  • In vivo studies using mouse models (PancO2 and SL4).
  • Assessment of TAM polarization and autophagy using techniques like flow cytometry, Western blotting, and electron microscopy.

Main Results:

  • Elevated Cat S expression correlates with advanced tumor stage, metastasis, and recurrence in colon cancer.
  • Cat S knockout reduced tumor growth and metastasis, and inhibited M2 macrophage polarization.
  • Cat S is essential for autophagic flux and autophagosome-lysosome fusion in TAMs, driving M2 polarization and tumor development.

Conclusions:

  • Cathepsin S-mediated autophagy is a critical mechanism for M2 TAM polarization, promoting colon cancer progression.
  • Targeting Cat S and its role in autophagy presents a promising strategy for colon cancer therapy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K